Biosimilar in lymphoma treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Auteur principal: | Tanisha, Mehrin Haque |
---|---|
Autres auteurs: | Kabir, Eva Rahman |
Format: | Thèse |
Langue: | English |
Publié: |
Brac University
2021
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/15533 |
Documents similaires
-
CAR-T cell Therapy in B-cell Lymphoma
par: Faruk, Asef
Publié: (2020) -
Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023) -
Biologics and Biosimilars as Treatment Options for Psoriasis
par: Moya, Amena Khatun
Publié: (2023) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
par: Tania, Umme
Publié: (2021)